Sort
16,300 grants matching “fatty liver disease”
GENE THERAPY FOR ALCOHOLIC LIVER DISEASE
$140,282John J Lemasters · Univ Of North Carolina Chapel Hill · P60 · FY2007 · AA
The gut-fat crosstalk in metabolic regulation
$140,116Eryun Zhang · Beckman Research Institute/City Of Hope · K01 · FY2025 · DK
Nucleosome architecture in aging and nuclear receptor activation in the liver
$139,752Irina Bochkis · Broad Institute, Inc. · K01 · FY2015 · DK
Nucleosome architecture in aging and nuclear receptor activation in the liver
$139,752Irina Bochkis · Broad Institute, Inc. · K01 · FY2014 · DK
Patient-Oriented Research of Liver Disease
$139,676Naga P. Chalasani · Indiana University Indianapolis · K24 · FY2011 · DK
Patient-Oriented Research of Liver Disease
$139,676Naga P. Chalasani · Indiana University Indianapolis · K24 · FY2014 · DK
Patient-Oriented Research of Liver Disease
$139,676Naga P. Chalasani · Indiana University Indianapolis · K24 · FY2013 · DK
Patient-Oriented Research of Liver Disease
$139,676Naga P. Chalasani · Indiana University Indianapolis · K24 · FY2012 · DK
Gene Delivery and Addiction
$139,453Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2018 · DA
OMEGA-3 FISH OIL SUPPLEMENTS VERSUS PLACEBO IN NON-ALCOHOLIC STEATOHEPATITIS
$139,412Stephen H Caldwell · University Of Virginia · M01 · FY2009 · RR
Immuno-modulatory Effects of Parenteral Nutrition After Intestinal Failure
$139,406Stephen H Benedict · University Of Kansas Medical Center · R21 · FY2007 · DK
BIOFORMATICS CORE
$139,333Bruce J. Aronow · Cincinnati Childrens Hosp Med Ctr · P30 · FY2013 · DK
The crosstalk between obesity-induced fatty liver and liver metastasis
$139,125Changyu Zhu · Sloan-Kettering Inst Can Research · K99 · FY2024 · CA
Association of Genomic Predictors of Body Fat Amount and Distribution and of tti
$138,863Iona C Cheng · University Of Hawaii At Manoa · P01 · FY2016 · CA
Apolipoprotein CIII inhibition in partial lipodystrophy
$138,779Rebecca Brown · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Hepatoprotective Mechanisms of TTC39B Deficiency
$138,480Joanne Hsieh · Columbia University Health Sciences · K01 · FY2018 · DK
Human Epidemiologic and Toxicity Assessment of Microcystin Mixture Effects on Hepatic Disease and Cancer
$138,147Astrid Schnetzer · North Carolina State University Raleigh · P01 · FY2024 · ES
Hepatocyte PPARgamma regulated mechanisms in NAFLD and lipid homeostasis
$138,021Jose Cordoba-Chacon · University Of Illinois At Chicago · K01 · FY2018 · DK
Impact of FGF21 on healthspan and lifespan
$138,000Vishwa Deep Dixit · Yale University · P01 · FY2017 · AG
SKELETAL MUSCLE DE NOVO LIPOGENESIS AND THE GLUCOSE-FATTY ACID CYCLE
$137,893Katsuhiko Funai · East Carolina University · K01 · FY2016 · DK
SKELETAL MUSCLE DE NOVO LIPOGENESIS AND THE GLUCOSE-FATTY ACID CYCLE
$137,893Katsuhiko Funai · East Carolina University · K01 · FY2015 · DK
SKELETAL MUSCLE DE NOVO LIPOGENESIS AND THE GLUCOSE-FATTY ACID CYCLE
$137,893Katsuhiko Funai · East Carolina University · K01 · FY2014 · DK
HCHS-SOL AE FIELD CENTER DIVERSITY SUPPLEMENT FOR DR. TREJO
$137,834Robert Kaplan · Albert Einstein College Of Medicine · N01 · FY2024 · HL
Role of ATGL in lipid droplet and nuclear lipidomes
$137,765Douglas G Mashek · University Of Minnesota · R01 · FY2013 · DK
Role of Ceramide in Hepatic Stellate Cell Activation and Liver Fibrosis
$137,700Jennifer Y. Chen · University Of California, San Francisco · K08 · FY2021 · DK